SLC1A2 and Huntington disease: Based on a previous study, showing that LPS treatment increases GLT-1 expression and glutamate uptake in microglia in a TNFα-dependent manner (Persson et al. 2005), the finding that LPS treatment improves the clinical symptoms of HD could be associated with a change in glutamate uptake.